Entering text into the input field will update the search result below

Osiris Therapeutics beats by $0.04, beats on revenue

  • Osiris Therapeutics (NASDAQ:OSIR): Q1 EPS of $0.04 beats by $0.04.
  • Revenue of $21M (+109.0% Y/Y) beats by $2.6M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
OSIR--
Osiris Therapeutics, Inc.